Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03521830
Brief Title: Nivolumab Alone or Plus Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

First Submitted : April 30, 2018
First Submitted that Met QC Criteria : April 30, 2018
First Posted : May 10, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : June 6, 2019
Last Update Posted : June 10, 2019